Replay available

Borregaard Asa (BRRDF) Q1 2026 Earnings Call

Borregaard Asa (OTC: BRRDF) Q1 2026 earnings conference call, held 2026-04-29. Replay captured from the company's public earnings webcast.

Wed, April 29, 2026 at 2:30 AMendedReplay
Borregaard Asa (BRRDF) Q1 2026 Earnings Call

Hosted by

Featured presenters

Tom-Erik Foss-Jakobsen

CEO

Paul Espen Ramberg

Director of Investor Relations

Per-Bjørn Lyngstad

CFO

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Borregaard Asa.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:06.261 Good morning and welcome to Borgard's first quarter 2026 presentation. 00:00:06.261 -- 00:00:11.469 My name is Tom-Erik Foss-Jakobsen. I'm the CEO of the company and I'll be joined today 00:00:11.469 -- 00:00:15.134 by our CFO, Per-Bjørn Lyngstad. 00:00:15.134 -- 00:00:17.938 Together we will take you through 00:00:17.938 -- 00:00:20.943 this agenda. 00:00:20.943 -- 00:00:25.610 I'll start with the key highlights for the quarter and then give an update on the market 00:00:25.610 -- 00:00:31.306 situation across our business segments. I'll then summarize the outlook 00:00:31.306 -- 00:00:36.695 before handing over to Per Bjarne who will walk you through the financial performance 00:00:36.695 -- 00:00:39.236 in more detail. 00:00:39.600 -- 00:00:44.889 Before we begin, just a quick reminder for those of you watching the webcast live 00:00:44.889 -- 00:00:51.120 that you're welcome to submit your questions at any time during the presentation 00:00:51.120 -- 00:00:55.344 and we will address them at the end of the presentation. 00:00:57.355 -- 00:00:59.778 Let's begin with the highlights 00:00:59.778 -- 00:01:02.261 for the first quarter. 00:01:02.261 -- 00:01:05.305 EBITDA came in at 428 00:01:05.305 -- 00:01:11.692 million Norwegian kroner compared with 511 million in the same quarter last year. 00:01:11.692 -- 00:01:17.640 In bio solutions, we saw lower sales volumes within specialties 00:01:17.640 -- 00:01:21.524 compared with a very strong quarter last year. 00:01:21.524 -- 00:01:27.141 In biomaterials, we delivered higher volumes but this was offset by lower 00:01:27.141 -- 00:01:31.425 sales prices and a weaker product mix. 00:01:31.448 -- 00:01:36.497 Fine chemicals delivered a strong result, supporting the overall performance i...